Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-20

FDA Approved: FEXINIDAZOLE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for fexinidazole submitted by Sanofi-Aventis U.S. LLC. This action updates the regulatory record for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexinidazole (fexinidazole)

Snippet

SUPPL AP for FEXINIDAZOLE (FEXINIDAZOLE)